Подписаться
Andriy Bazylevych, A Basylevych, A Bazilevich, A Bazilevych, Андрій Базилевич, А Базилевич,
Andriy Bazylevych, A Basylevych, A Bazilevich, A Bazilevych, Андрій Базилевич, А Базилевич,
Professor Danylo Halytsky Lviv National Medical University
Подтвержден адрес электронной почты в домене meduniv.lviv.ua
Название
Процитировано
Процитировано
Год
Apixaban versus warfarin in patients with atrial fibrillation
CB Granger, JH Alexander, JJV McMurray, RD Lopes, EM Hylek, ...
New England Journal of Medicine 365 (11), 981-992, 2011
108352011
Edoxaban versus warfarin in patients with atrial fibrillation
RP Giugliano, CT Ruff, E Braunwald, SA Murphy, SD Wiviott, JL Halperin, ...
New England Journal of Medicine 369 (22), 2093-2104, 2013
58012013
Eplerenone in patients with systolic heart failure and mild symptoms
F Zannad, JJV McMurray, H Krum, DJ van Veldhuisen, K Swedberg, H Shi, ...
New England Journal of Medicine 364 (1), 11-21, 2011
36752011
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
K Swedberg, M Komajda, M Böhm, JS Borer, I Ford, A Dubost-Brama, ...
The Lancet 376 (9744), 875-885, 2010
33202010
Alogliptin after acute coronary syndrome in patients with type 2 diabetes
WB White, CP Cannon, SR Heller, SE Nissen, RM Bergenstal, GL Bakris, ...
New England Journal of Medicine 369 (14), 1327-1335, 2013
30942013
Rivaroxaban with or without aspirin in stable cardiovascular disease
JW Eikelboom, SJ Connolly, J Bosch, GR Dagenais, RG Hart, ...
New England Journal of Medicine 377 (14), 1319-1330, 2017
23522017
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)
Marcus D. Flather, Marcelo C. Shibata, Andrew J.S. Coats, on behalf of the ...
European Heart Journal 26 (3), 215-225, 2005
22942005
Long-term use of ticagrelor in patients with prior myocardial infarction
MP Bonaca, DL Bhatt, M Cohen, PG Steg, RF Storey, EC Jensen, ...
New England Journal of Medicine 372 (19), 1791-1800, 2015
21382015
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
K Fox, I Ford, PG Steg, M Tendera, R Ferrari, B Investigators, ...
The Lancet 372 (9641), 807-816, 2008
14632008
Tiotropium versus salmeterol for the prevention of exacerbations of COPD
C Vogelmeier, B Hederer, T Glaab, H Schmidt, MPMH Rutten-van Mölken, ...
New England Journal of Medicine 364 (12), 1093-1103, 2011
9602011
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ...
The Lancet 391 (10117), 219-229, 2018
9252018
Ivabradine in stable coronary artery disease without clinical heart failure
K Fox, I Ford, PG Steg, JC Tardif, M Tendera, R Ferrari, SIGNIFY, ...
New England Journal of Medicine 371 (12), 1091-1099, 2014
6192014
Darapladib for preventing ischemic events in stable coronary heart disease
Stability Investigators
New England Journal of Medicine 370 (18), 1702-1711, 2014
5512014
Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial
JC Tardif, P Ponikowski, T Kahan, ASSOCIATE, study Investigators, ...
European Heart Journal 5 (30), 540–548, 2009
5092009
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
SJ Connolly, JW Eikelboom, J Bosch, G Dagenais, L Dyal, F Lanas, ...
The Lancet 391 (10117), 205-218, 2018
3982018
Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized …
M Jadzinsky, A Pfützner, E Paz‐Pacheco, Z Xu, E Allen, R Chen, ...
Diabetes, Obesity and Metabolism 11 (6), 611-622, 2009
3942009
Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial
JD Easton, RD Lopes, MC Bahit, DM Wojdyla, CB Granger, L Wallentin, ...
The Lancet Neurology 11 (6), 503-511, 2012
3682012
Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries
De Backer G, Jankowski P, Kotseva K, Mirrakhimov E, Reiner Z, Rydén L ...
Atherosclerosis 285, 135-146, 2019
3032019
Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme …
K Kotseva, G De Backer, D De Bacquer, L Rydén, A Hoes, D Grobbee, ...
European Journal of Preventive Cardiology 28 (4), 370-9, 2021
1472021
The BEAUTIFUL study: randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction–baseline characteristics of the …
VM Maria da Consolação, S Heringer-Walther, N Wessel, TM Ventura, ...
Cardiology 110 (4), 271-282, 2008
892008
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20